Soliton Inc. (SOLY) NASDAQ

$22.58 0 (0.00%)

Market Cap: $0

As of 12/15/21 12:00 AM EST. Market closed.

(SOLY)

Soliton Inc. (SOLY) NASDAQ

$22.58 0 (0.00%)

Market Cap: $0

As of 12/15/21 12:00 AM EST. Market closed.

Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer Center. TheCompany's first FDA cleared commercial product, RESONIC™, will use rapid pulses of acoustic shockwaves as an accessory to lasers for the removal of unwanted tattoos and the treatment of cellulite. The Company is based in ... read more

Soliton, Inc. is a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of MD Anderson Cancer Center. TheCompany's first FDA cleared commercial product, RESONIC™, will use rapid pulses of acoustic shockwaves as an accessory to lasers for the removal of unwanted tattoos and the treatment of cellulite. The Company is based in Houston, Texas, and is actively engaged in bringing RESONIC to the market. The Company believes this "Soliton" method has the potential to lower tattoo removal costs for patients, while increasing profitability to practitioners, compared to current laser removal methods. The Company also believes the technology will provide the first non-invasive acoustic technology to target the underlying causes of dimples and ridges in cellulite. Soliton is investigating potential additional capabilities of the RAP technology. The device is currently cleared in the United States only for use in tattoo removal and cellulite. read less

COMPANY PROFILE
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
CEO Compensation (Base)
$300,000
CEO Compensation (Total)
$1.22M
URL
Address
.
Sector
Manufacturing
Industry
Surgical and Medical Instrument Manufacturing
Full Time Employees
14
CEO Compensation (Base)
$300,000
CEO Compensation (Total)
$1.22M
Address
.
PRICE CHART
1w
1m
3m
6m
YTD
1y
5y
MAX
From: To:
KEY STATS
Open
$0
Previous Close
$22.58
Days Range
$22.56 - $22.59
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
21,596,544
Open
$0
Previous Close
$22.58
Days Range
$22.56 - $22.59
52 week range
$0 - $0
Volume
0
Avg. Volume (30 days)
0
Market Cap
$0
Dividend Yield
0.00%
P/E
-
Shares Outstanding
21,596,544

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

Open in: SeekingAlpha Yahoo Finance Fidelity MorningStar

INSIDER TRANSACTIONS FOR SOLITON INC
Owner Relationship Date Transaction Cost # Shares Value($) Total Shares Form 4
TANNER JOE D Chief Operating Officer Dec 16, 2021 Option Exercise $22.60 80,000 1,808,000 0 Dec 17, 2021, 05:10 PM
Remeditex Ventures LLC 10% Owner Dec 16, 2021 Option Exercise $22.60 9,214,277 208,242,664 0 Dec 17, 2021, 05:09 PM
KLEMP WALTER V Executive Chairman Dec 16, 2021 Option Exercise $22.60 425,000 9,605,000 0 Dec 17, 2021, 05:09 PM
Capelli Christopher CSO and Vice Chairman Dec 16, 2021 Option Exercise $22.60 175,000 3,955,000 0 Dec 17, 2021, 05:07 PM
Capelli Christopher CSO and Vice Chairman Dec 16, 2021 Option Exercise $22.60 263,440 5,953,744 0 Dec 17, 2021, 05:07 PM
Bisson Lori Chief Financial Officer Dec 16, 2021 Option Exercise $22.60 60,000 1,356,000 0 Dec 17, 2021, 05:06 PM
Remeditex Ventures LLC 10% Owner Jun 30, 2020 Buy $8.30 120,481 999,992 9,214,277 Jul 01, 2020, 08:30 PM
Buy Sale Option Exercise
Owner Relationship Date Value($)
TANNER JOE D Chief Operating Officer 12/16/2021 1,808,000
Remeditex Ventures LLC 10% Owner 12/16/2021 208,242,664
KLEMP WALTER V Executive Chairman 12/16/2021 9,605,000
Capelli Christopher CSO and Vice Chairman 12/16/2021 3,955,000
Capelli Christopher CSO and Vice Chairman 12/16/2021 5,953,744
Bisson Lori Chief Financial Officer 12/16/2021 1,356,000
Remeditex Ventures LLC 10% Owner 06/30/2020 999,992
CHANGE IN SHARES OUTSTANDING
STOCK BUYBACKS
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
06/30/2021
03/31/2021
1.53%
1Q
06/30/2021
12/31/2020
13.13%
2Q
06/30/2021
09/30/2020
17.54%
3Q
06/30/2021
06/30/2020
27.50%
4Q
06/30/2021
03/31/2020
27.79%
5Q
Load More

Period of Report: 06/30/2021

10-K/10-Q Filings: View

Previous Period
% Change in Shares
Quarter
03/31/2021
1.53%
1Q
12/31/2020
13.13%
2Q
09/30/2020
17.54%
3Q
06/30/2020
27.50%
4Q
03/31/2020
27.79%
5Q
Load More